Related Experiment Video
Updated: Jan 30, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis
Guanqun Li1, Fuquan Jin1, Jiangxia Du1
1Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology & Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Abstract:
Idiopathic pulmonary fibrosis is a pathological result of dysfunctional repair response to tissue injury, leading to chronically impaired gas exchange and death. Macrophages are believed to be critical in this disease pathogenesis; However, the exact mechanisms remain enigmatic. Here, we demonstrated that macrophages might contribute to pulmonary fibrosis at the early stage because the aggregation of macrophages appeared earlier than epithelial-mesenchymal transition and fibrosis in mouse and rat experimental models of pulmonary fibrosis. It has been found that macrophages could promote epithelial-mesenchymal transition of alveolar epithelial cells and fibroblast migration in co-culture models between macrophages and alveolar epithelial cells/fibroblasts. Importantly, we used protein micro array to analyze the cytokines that were altered after bleomycin treatment. Only thymic stromal lymphopoietin and matrix metalloproteinase 9 were significantly increased. We further confirmed that TSLP participated in the macrophage-induced epithelial-mesenchymal transition of alveolar epithelial cells using a TSLP recombinant protein. MMP9 was also involved in macrophage-induced fibroblast migration, which can be reversed by an inhibitor of MMP9. Collectively, these findings explained the underlying mechanisms of macrophage-promoted pulmonary fibrosis.
Insights
Macrophages promote early pulmonary fibrosis by driving alveolar epithelial cells to undergo epithelial-mesenchymal transition and aiding fibroblast migration. Thymic stromal lymphopoietin and matrix metalloproteinase 9 are key mediators in this process.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Immunology
Background:
- Idiopathic pulmonary fibrosis (IPF) involves a faulty repair response to lung injury, impairing gas exchange.
- Macrophages are implicated in IPF pathogenesis, but their precise role remains unclear.
- Early macrophage aggregation precedes fibrosis development in experimental models.
Purpose of the Study:
- To elucidate the mechanisms by which macrophages contribute to pulmonary fibrosis.
- To identify specific molecular mediators involved in macrophage-driven fibrotic processes.
Main Methods:
- Utilized mouse and rat models of pulmonary fibrosis.
- Employed co-culture systems of macrophages with alveolar epithelial cells and fibroblasts.
- Analyzed cytokine profiles using protein microarrays after bleomycin treatment.
- Investigated the role of thymic stromal lymphopoietin (TSLP) and matrix metalloproteinase 9 (MMP9) using recombinant proteins and inhibitors.
Main Results:
- Macrophage aggregation was observed prior to epithelial-mesenchymal transition (EMT) and fibrosis in experimental models.
- Macrophages promoted EMT in alveolar epithelial cells and fibroblast migration in co-culture.
- TSLP and MMP9 levels were significantly elevated post-bleomycin treatment.
- TSLP mediated macrophage-induced alveolar epithelial cell EMT; MMP9 mediated macrophage-induced fibroblast migration.
Conclusions:
- Macrophages play a critical role in the early stages of pulmonary fibrosis.
- TSLP and MMP9 are key cytokines mediating macrophage-induced EMT and fibroblast migration, respectively.
- These findings reveal underlying mechanisms of macrophage-promoted pulmonary fibrosis.
More Related Videos
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Anaphase Promoting Complex
Regulation of Hormone Secretion
Humoral...

